A retrospective study in Japan compared the change of renal function in patients with diabetes and chronic kidney disease before and after intravitreal administration of VEGF inhibitors; the result suggested that the therapy is not associated with renal function deterioration during the 7–30-day period [22]. The gene discussed is VEGFA; the disease is chronic kidney disease.